An attractive smile enhances an individual's self-confidence. The overall harmony of a smile can be attributed to the interplay of the teeth's shape, color, and position along with the gingival tissue. Gingival pigmentation is observed across all human races, exhibiting variations from one race to another. Typically, gingival hyperpigmentation results from the abnormal buildup of melanin in the gingival tissue, imparting a dark appearance on the gums. Various procedures, collectively known as gingival depigmentation, are employed to address gingival hyperpigmentation. While the initial outcomes of depigmentation procedures are often promising, one common issue associated with them is the potential for re-pigmentation. This article aims to evaluate the clinical effectiveness and patient-reported outcomes of intraepidermal (oral mesotherapy) vitamin C injection for nonsurgical management of physiologic gingival melanin hyperpigmentation.
Background: Periodontal disease is a chronic inflammatory disease that activates the innate immune response. Activation of the TREM-1 signaling pathway promotes the synthesis of inflammatory cytokines like interleukin-1 beta (IL-1β), tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6) and interleukin-8 (IL-8). Hyaluronic acid (HA) can be used to treat periodontitis as an adjunct to mechanical debridement due to its healing properties. Objectives: To evaluate and compare soluble triggering receptor expressed on myeloid cells (sTREM-1) and IL-1β in periodontitis patients with and without diabetes mellitus before and after nonsurgical periodontal therapy using conventional root planing and adjuncts like HA (Gengigel ® ) and diode LASER (940 nm). Materials and Methods: Chronic periodontitis patients were allocated to groups based on with and without diabetes mellitus (groups I and II), respectively. Assessment of periodontal parameters: periodontal probing depth (PPD), clinical attachment loss (CAL), plaque index (PI), gingival bleeding index (GBI), and periodontal inflammatory surface area (PISA) index were done. About 5 mL of unstimulated whole saliva was collected from every patient at baseline and 1 month. Patients were subgrouped based on the treatment protocol (subgroup A: conventional scaling and root planing (SRP), subgroup B: SRP + HA (0.8% Gengigel ® ), and subgroup C: SRP + 940 nm diode LASER). The primary and secondary outcomes before and after therapy were determined. Results: Intragroup comparison of group I showed the statistical significance of parameters in subgroups B and C. Intragroup comparison of group II in all three subgroups. Intergroup comparison of groups II and III showed the statistical significance of all periodontal parameters and salivary biomarker levels in A–C subgroups. Conclusion: Therefore, within the study’s limitations, the use of adjuncts to nonsurgical periodontal therapy in chronic periodontitis had an additional improvement in all clinical parameters and salivary biomarkers over conventional root planing.
1 December 2023 in Journal of Pharmacology and Pharmacotherapeutics
Background: Subgingival plaque biofilm is a potential harboring site for bacteria and viruses, serving as a source of entry into the bloodstream. The presence of Severe Acute Respiratory Syndrome Coronavirus 2 RNA (SARS-CoV-2 RNA) in subgingival plaque could be a possible source for cross infection due to aerosol contamination during dental procedures. Objectives: The objective of this study was to investigate the presence of SARS-CoV-2 RNA in the subgingival plaque biofilm of patients who recovered from COVID-19 infection. Materials and Methods: Ten subjects visiting the Outpatient clinic with a previous history of COVID-19 infection were recruited for this cross-sectional study. Subgingival plaque sample was collected from all four quadrants using a sterile curette. Nasopharyngeal and oropharyngeal swabs were taken from all the subjects. Reverse transcriptase real-time qualitative polymerase chain reaction (RT-PCR) was used to determine the presence of SARS-CoV-2 RNA using BAG SARS-CoV-2 RT-PCR kit targeting E gene, RdRp gene, and internal control. Results: Ten participants (seven females and three males) with a previous history of COVID-19 infection were included in the study. Six participants previously presented with mild COVID-19 infection (uncomplicated upper respiratory tract infection, mild fever, cough, sore throat, nasal congestion, malaise, headache, without evidence of breathlessness or hypoxia), and four participants previously presented with moderate COVID-19 infection (dyspnea and or hypoxia, fever, cough, SpO2 90%–94% on room air, respiratory rate more or equal to 24 per minute) according to clinical management protocol for COVID-19, Government of India. The nasopharyngeal, oropharyngeal, and subgingival plaque samples tested negative for SARS-CoV-2 RNA. Conclusion: The absence of the SARS-CoV-2 virus in the subgingival plaque sample of patients recovered from COVID-19 infection suggests that dental plaque could not be a potential reservoir of the virus. However, clinicians should take at most precautions while treating the patients recovered from COVID-19 infection and should anticipate a change in subgingival environment leading to alteration in periodontal disease progression.